Skip to main content
Equibles
GDRX logo

GDRX · GoodRx Holdings, Inc. · Metrics

Track GDRX — free

Use GDRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GDRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.51 +0.02 (+0.57%) At close · Nov 6 Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$1.19B
Shares
341.15M
Volume · Nov 6 1.17M Avg daily vol (3M) 1.23M

GDRX metrics

102 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.51
Market cap
$1.19B

Price action

23 metrics
Price change (1W)
-1.4%
Price change (30D)
+7.4%
Price change (3M)
-6.2%
Price change (6M)
+22.9%
Price change (YTD)
+28.8%
Price change (1Y)
+4.8%
Trailing year
Price change (5Y)
-92.0%
52-week high
$3.80
52-week low
$1.87
Change from 52-week high
-8.2%
Change from 52-week low
+86.6%
Annualized volatility
56.0%
Annualized volatility (3M)
49.0%
Implied volatility (30D)
—
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.3
RSI (14D)
50.4
Price vs SMA 50
+1.6%
Price vs SMA 200
+23.0%
Avg volume (3M)
1.28M
Relative volume
1.0
Average dollar volume
$4.50M

Company

3 metrics
Sector
Healthcare
Industry
Health Information Services
Shares outstanding
341.15M

Valuation

12 metrics
P / E (TTM)
87.3
Trailing earnings · reciprocal yield 1.1%
PEG ratio
—
EV / revenue
1.8×
reciprocal yield 56.9%
EV / EBITDA
8.4×
reciprocal yield 11.8%
EV / EBIT
18.4×
reciprocal yield 5.4%
P / sales
1.5×
reciprocal yield 66.0%
P / book
1.8
reciprocal yield 54.4%
FCF yield
16.6%
TTM · current market cap
Buyback yield
7.1%
P / FCF
6.0
reciprocal yield 16.6%
P / operating cash flow
5.9
reciprocal yield 16.9%
Earnings yield
1.4%

Historical valuation

8 metrics
P / E historical average (3Y)
106.6×
reciprocal yield 0.9%
P / E historical average (5Y)
106.6×
reciprocal yield 0.9%
EV / revenue historical average (3Y)
2.5×
reciprocal yield 39.9%
EV / revenue historical average (5Y)
4.8×
reciprocal yield 20.7%
EV / EBIT historical average (3Y)
43.2×
reciprocal yield 2.3%
EV / EBIT historical average (5Y)
169.1×
reciprocal yield 0.6%
EV / EBITDA historical average (3Y)
19.2×
reciprocal yield 5.2%
EV / EBITDA historical average (5Y)
29.3×
reciprocal yield 3.4%

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
7.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
9.5%
Trailing 12 months
Net margin
2.1%
Gross profit (TTM)
—
Operating profit (TTM)
$74.94M
Net income (TTM)
$16.25M
Trailing 12 months
Diluted EPS (TTM)
$0.04
FCF margin
25.1%
Effective tax rate
60.7%

Per share

11 metrics
Revenue per diluted share (TTM)
$2.27
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$0.22
EBITDA per diluted share (TTM)
$0.47
Net income per diluted share (TTM)
$0.05
Operating cash flow per diluted share (TTM)
$0.58
Free cash flow per diluted share (TTM)
$0.57
Capital expenditures per diluted share (TTM)
$0.01
R&D per diluted share (TTM)
$0.34
Stock compensation per diluted share (TTM)
$0.20
Book value per share
—

Growth

11 metrics
Revenue growth YoY
-1.3%
Year over year
Net income growth YoY
-33.5%
Revenue (TTM)
$785.23M
Trailing 12 months
EPS growth YoY
-50.0%
Shares change YoY
-2.5%
Year over year · fewer shares
Revenue CAGR (3Y)
+1.3%
Revenue CAGR (5Y)
+7.7%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+4.8%
FCF CAGR (5Y)
+8.2%

Quality

14 metrics
Return on equity
2.5%
Return on assets
0.7%
Debt / equity
0.8
Current ratio
1.4
EBITDA (TTM)
$163.58M
Free cash flow (TTM)
$197.09M
Quick ratio
1.4
Interest coverage
1.8
Net debt / EBITDA
1.2
Return on invested capital
3.5%
Trailing 12 months
Net cash
−$190.47M
Latest balance sheet
Cash & equivalents
$296.11M
Total assets
$2.34B
Total debt
$486.59M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$201.58M
Capital expenditures (TTM)
$4.49M
R&D (TTM)
$116.84M
SG&A (TTM)
—
Stock compensation (TTM)
$69.14M
R&D / revenue
14.9%
Stock compensation / revenue
8.8%

Ownership (13F)

9 metrics
13F filers
164
13F filer change QoQ
-14
Institutional ownership
35.1%
Conviction holders (share of 13F filers)
2.5%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+2.7%
Holder tenure
17.8
Price vs estimated holder cost
-47.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
2.7%

Short interest

3 metrics
Short interest
1.1%
Latest settlement · 4.2 days to cover
Days to cover
4.2d
Short-squeeze score
48 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1809519 CUSIP 38246G108 13F (30d) 78 filings 66 filers Visit website Investor relations